Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

New Line of Laboratory Balances Focuses on Most Often Used Weighing Tasks

By BiotechDaily International staff writers
Posted on 08 May 2014
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Biotech and other life science researchers can increase their productivity by selecting one or more new laboratory balances from an innovative new line.

Sartorius (Gottingen, Germany) recently introduced the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions.

The line of Entris balances comprised 15 analytical and precision balances that cover a weighing capacity from 60 grams to 8.2 kilograms with a readability of 0.1 milligram to 0.1 gram.

The logical key assignment on the Entris and its clearly structured user interface make daily routine weighing much easier. Most models of the new Entris family are equipped with a monolithic weighing system featuring external adjustment or an internal, motorized adjustment function. This guarantees consistently accurate weighing results, which are displayed on the easy-to-read backlit, high-contrast display.

The Entris system, which can display information in German, English, French, Italian, Spanish, Russian and Polish, is equipped with applications for density determination, animal weighing, counting, conversion, and weighing in percent. The easily removable draft shield and stainless steel parts render the Entris quick and easy to clean.

Related Links:
Sartorius

comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Drug Discovery

view channel
Image: The five stages of biofilm development: (1) Initial attachment, (2) Irreversible attachment, (3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of development in the diagram is paired with a photomicrograph of a developing P. aeruginosa biofilm. All photomicrographs are shown to same scale (Photo courtesy of Wikimedia Commons).

Ionic Liquids Disperse Bacterial Biofilms and Increase Antibiotic Susceptibility

The ionic liquid choline-geranate was shown to effectively eliminate the protective biofilm generated by bacteria such as Salmonella enterica and Pseudomonas aeruginosa and to significantly increase the... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel

Important Immune Cell Regulators’ Response Identified

A new strategy could help accelerate laboratory research and the development of potential therapeutics, including vaccines. The technology may also be used to identify the genes that underlie tumor cell development. There are approximately 40,000 genes in each of the body’s cells, but functions for only approximately... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.